Where the fear came from
In 2002 a large US study, the Women's Health Initiative, was reported as showing that HRT caused breast cancer. Prescriptions dropped worldwide. Later analysis showed the women studied were older on average (around 63), and the absolute increase in risk was small. Women starting HRT around menopause have a different risk profile.
What we know now
- Estrogen-only therapy (for women without a womb) shows little or no increase in breast cancer risk
- Combined therapy is linked with a small increase that rises with longer use and falls after stopping
- Lifestyle factors such as alcohol and excess weight carry comparable or larger risks
- In November 2025, the US FDA began removing the boxed warnings from menopausal hormone therapy labels
Who should usually avoid HRT
Women with a history of breast cancer or other hormone-sensitive cancers usually shouldn't take systemic HRT. Non-hormonal options are available for them.
How we decide
Your age, family history, breast screening, type of hormones, route and duration are all reviewed before anything is prescribed, and again every year. More about hormone therapy →
This article is for general education and is not medical advice. Results vary from person to person.
